NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up Status COMPLETED Phase N/A
NCT01195727 Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter Status TERMINATED Phase PHASE1
NCT01195662 A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Status COMPLETED Phase PHASE3
NCT01194856 Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression Status TERMINATED Phase PHASE4
NCT01192659 Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT01188278 Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey Status COMPLETED Phase N/A
NCT01176474 Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma Status COMPLETED Phase PHASE1
NCT01176461 Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558 Status COMPLETED Phase PHASE1
NCT01173679 Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL Status TERMINATED Phase PHASE2
NCT01170962 Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment Status COMPLETED Phase PHASE2
NCT01167244 Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response Status COMPLETED Phase PHASE2
NCT01166620 Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics Status COMPLETED Phase N/A
NCT01165268 Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT01165216 Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer Status COMPLETED Phase PHASE1